Publications by Computational Biology and Bioinformatics Kartsonaki, C. et al. (2023) “Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19”, International Journal of Epidemiology, 52(2), pp. 355–376. Lu, Y., Reinert, G. and Cucuringu, M. (2023) “Co-trading networks for modeling dynamic interdependency structures and estimating high-dimensional covariances in US equity markets”, arXiv. Lu, Y., Reinert, G. and Cucuringu, M. (2023) “Co-Trading Networks for Modeling Dynamic Interdependency Structures and Estimating High-Dimensional Covariances in US Equity Markets”, SSRN Electronic Journal. Eales, O. et al. (2023) “The use of representative community samples to assess SARS-CoV-2 lineage competition: Alpha outcompetes Beta and wild-type in England from January to March 2021”, Microbial Genomics, 9(2). Penn, M. and Donnelly, C. (2023) “Asymptotic analysis of optimal vaccination policies”, Bulletin of Mathematical Biology, 85. Agarwal, I. et al. (2023) “Relating pathogenic loss-of-function mutations in humans to their evolutionary fitness costs”, eLife, 12, p. e83172. Raybould, M. et al. (2023) “Computationally profiling peptide: MHC recognition by T-cell receptors and T-cell receptor-mimetic antibodies”, Frontiers in Immunology, 13. McCabe, R. et al. (2023) “Alternative epidemic indicators for COVID-19: a model-based assessment of COVID-19 mortality ascertainment in three settings with incomplete death registration systems”, medRxiv. Spoendlin, F. et al. (2023) “Improved computational epitope profiling using structural models identifies a broader diversity of antibodies that bind the same epitope”, bioRxiv. Watson, L. et al. (2023) “Improving estimates of epidemiological quantities by combining reported cases with wastewater data: a statistical framework with applications to COVID-19 in Aotearoa New Zealand”, medRxiv. Previous page ‹‹ … Page 13 Page 14 Page 15 Page 16 Current page 17 Page 18 Page 19 Page 20 Page 21 … Next page ››